OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Immune System With Pharmacotherapy in Schizophrenia
Jennifer K. Melbourne, Benjamin Feiner, Cherise Rosen, et al.
Current Treatment Options in Psychiatry (2017) Vol. 4, Iss. 2, pp. 139-151
Open Access | Times Cited: 13

Showing 13 citing articles:

The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
Esmé Jansen van Vuren, Stephan F. Steyn, C. Brink, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 135, pp. 111200-111200
Open Access | Times Cited: 97

Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment
Marcella Reale, Erica Costantini, Nigel H. Greig
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 76

Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia
N. А. Shnayder, Aiperi K. Khasanova, Anna Strelnik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11324-11324
Open Access | Times Cited: 24

Identification of biomarkers related to propionate metabolism in schizophrenia
Wei Xie, Zhihong Luo, Jiang Xiao, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access

Traumagenics: At the intersect of childhood trauma, immunity and psychosis
Kayla A. Chase, Jennifer K. Melbourne, Cherise Rosen, et al.
Psychiatry Research (2018) Vol. 273, pp. 369-377
Closed Access | Times Cited: 25

The JAK-STAT1 transcriptional signature in peripheral immune cells reveals alterations related to illness duration and acuity in psychosis
Jennifer K. Melbourne, Cherise Rosen, Benjamin Feiner, et al.
Brain Behavior and Immunity (2018) Vol. 77, pp. 37-45
Open Access | Times Cited: 8

Selected risk factors for schizophrenia: between the diversity of aetiological models and personalised psychiatry
Natalia Śmierciak, Wirginia Krzyściak, Marta Szwajca, et al.
Psychiatria i Psychologia Kliniczna (2018) Vol. 18, Iss. 4, pp. 388-398
Open Access | Times Cited: 4

Efficacy difference of antipsychotics in Alzheimer’s disease and schizophrenia: explained with network efficiency and pathway analysis methods
Peihao Fan, Julia Kofler, Ying Ding, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 3

Family Therapy for a Korean Son with Schizophrenia
Jinyoung Park, Yangjin Park, Tai‐Young Park
Australian and New Zealand Journal of Family Therapy (2017) Vol. 38, Iss. 3, pp. 529-539
Closed Access | Times Cited: 2

The Importance of Psychoneuroimmunology for Social Workers
Jill Littrell
Families in Society The Journal of Contemporary Social Services (2018) Vol. 100, Iss. 1, pp. 17-33
Open Access | Times Cited: 2

Atypical Antipsychotic Medications Disrupt the Cardio-Metabolic and Cardio-Immune Axes
Bahman Rostama, Meghan May, KL Houseknecht
Interventional Cardiology (2020) Vol. 12, Iss. 2
Open Access | Times Cited: 2

Page 1

Scroll to top